Primary Site >> Stomach Cancer

Gene >> MMP3

  • 1990
  • 1991
  • 1994
  • 1996
  • 1998
  • 2005
  • 2007
  • 2010
  • 2011
  • 2012
  • 2013
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28.
PMID: 2168868
Ref: Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
PMID: 1793490
Ref: Expression of type-IV collagenases in human tumor cell lines that can form liver colonies in chick embryos.
PMID: 8262676
Ref: Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
PMID: 8600068
Ref: Expression of c-fos gene inhibits proteoglycan synthesis in transfected chondrocyte.
PMID: 8601460
Ref: Matrix metalloproteinases and their inhibitors in gastric cancer.
PMID: 9824606
Ref: Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
PMID: 15389640
Ref: Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
PMID: 17617834
Ref: Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
PMID: 17913445
Ref: Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival.
PMID: 19690958
Ref: KITENIN is associated with tumor progression in human gastric cancer.
PMID: 20944126
Ref: Identification and validation of genes involved in gastric tumorigenesis.
PMID: 21092330
Ref: [The role of matrixmetalloproteinases in the tumor growth and metastasis].
PMID: 21972705
Ref: Silencing of the MMP-3 gene by siRNA transfection in gastric cancer AGS cells.
PMID: 21451793
Ref: Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its clinical significance.
PMID: 22848309
Ref: Identification of potential serum biomarkers for gastric cancer by a novel computational method, multiple normal tissues corrected differential analysis.
PMID: 22057037
Ref: Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population.
PMID: 22121090
Ref: Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10.
PMID: 22285823
Ref: Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.
PMID: 23644699
Ref: Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3.
PMID: 23705892
Ref: Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.
PMID: 23825909
Ref: Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer.
PMID: 23847441
Ref: IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway.
PMID: 25655003
Ref: Heterozygosity of stromelysin-1 (rs3025058) promoter polymorphism is associated with gastric cancer.
PMID: 26853425
Ref: CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-kappaB signaling pathway.
PMID: 26242263
Ref: Matrix metalloproteinase expression and molecular interaction network analysis in gastric cancer.
PMID: 27698806
Ref: Immunohistochemical expression and localization of cytokines/chemokines/growth factors in gastric cancer.
PMID: 27793525
Ref: Polymorphisms in matrix metalloproteinases 2, 3, and 8 increase recurrence and mortality risk by regulating enzyme activity in gastric adenocarcinoma.
PMID: 29285307
Ref: MEG3/miR21 axis affects cell mobility by suppressing epithelialmesenchymal transition in gastric cancer.
PMID: 29749532
Ref: MiR-361-5p inhibits the mobility of gastric cancer cells through suppressing epithelial-mesenchymal transition via the Wnt/beta-catenin pathway.
PMID: 29960070